Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.20% |
| Dec 31, 2025 | -5.97% |
| Sep 30, 2025 | 11.63% |
| Jun 30, 2025 | 9.17% |
| Mar 31, 2025 | 5.30% |
| Dec 31, 2024 | 2.99% |
| Sep 30, 2024 | 14.89% |
| Jun 30, 2024 | 49.30% |
| Mar 31, 2024 | 9.38% |
| Dec 31, 2023 | 7.17% |
| Sep 30, 2023 | 11.13% |
| Jun 30, 2023 | 11.92% |
| Mar 31, 2023 | 11.34% |
| Dec 31, 2022 | 47.15% |
| Sep 30, 2022 | 27.64% |
| Jun 30, 2022 | 17.05% |
| Mar 31, 2022 | 31.36% |
| Dec 31, 2021 | 54.51% |
| Sep 30, 2021 | 43.87% |
| Jun 30, 2021 | 73.66% |
| Mar 31, 2021 | 43.80% |
| Dec 31, 2020 | 49.28% |
| Sep 30, 2020 | 31.97% |
| Jun 30, 2020 | 35.75% |
| Mar 31, 2020 | 52.38% |
| Dec 31, 2019 | 49.83% |
| Sep 30, 2019 | 51.69% |
| Jun 30, 2019 | 14.92% |
| Mar 31, 2019 | 46.51% |
| Dec 31, 2018 | 56.94% |
| Sep 30, 2018 | 33.30% |
| Jun 30, 2018 | 44.55% |
| Mar 31, 2018 | 37.05% |
| Dec 31, 2017 | -18.08% |
| Sep 30, 2017 | 15.19% |
| Jun 30, 2017 | 38.26% |
| Mar 31, 2017 | 84.48% |
| Dec 31, 2016 | 46.45% |
| Sep 30, 2016 | 44.25% |
| Jun 30, 2016 | 38.73% |
| Mar 31, 2016 | 43.92% |
| Dec 31, 2015 | 66.03% |
| Sep 30, 2015 | 52.36% |
| Jun 30, 2015 | 57.33% |
| Mar 31, 2015 | 35.04% |
| Dec 31, 2014 | -28.57% |
| Sep 30, 2014 | 142.66% |
| Jun 30, 2014 | 53.24% |